 |
abatacept |
|---|---|
| Trade Name | |
| Orphan Indication | Idiopathic inflammatory myopathy (IIM) |
| USA Market Approval | USA |
| USA Designation Date | 2017-02-22 00:00:00 |
| Sponsor | Bristol-Myers Squibb Research & Development;Marketed Products Development - Regulatory Strategy, P.O. Box 5326;Princeton, New Jersey, 08543 |
